Bonde, T.M. et al. 2022. Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists. Scandinavian Journal of Urology. 56, 3 (May 2022), 169–175. DOI:https://doi.org/10.1080/21681805.2022.2070275.